Prevalence of attention-deficit/hyperactivity disorder in people with mood disorders: A systematic review and meta-analysis.


Journal

Acta psychiatrica Scandinavica
ISSN: 1600-0447
Titre abrégé: Acta Psychiatr Scand
Pays: United States
ID NLM: 0370364

Informations de publication

Date de publication:
05 2021
Historique:
revised: 13 01 2021
received: 23 05 2020
accepted: 21 01 2021
pubmed: 3 2 2021
medline: 19 8 2021
entrez: 2 2 2021
Statut: ppublish

Résumé

Attention-deficit/hyperactivity disorder (ADHD) in mood disorders is associated with unfavorable outcomes, including more frequent mood episodes, and increased risk of suicide. The reported prevalence of ADHD in individuals with mood disorders varies widely. We searched PsycInfo and PubMed for articles published before September 21 Based on 92 studies including 17089 individuals, prevalence of ADHD in BD is 73% (95% CI 66-79) in childhood, 43% (95% CI 35-50) in adolescence, and 17% (95% CI 14-20) in adulthood. Data from 52 studies with 16897 individuals indicated that prevalence of ADHD in MDD is 28% (95% CI 19-39) in childhood, 17% (95% CI 12-24) in adolescence, and 7% (95% CI 4-11) in adulthood. ADHD was three times more common in people with mood disorders compared to those without and 1.7 times more common in BD compared to MDD. People with mood disorders are at a significant risk for ADHD. ADHD should be assessed and treated in individuals with BD and MDD. Comprehensive assessment strategies are needed to address challenges of diagnosing ADHD alongside mood disorders.

Identifiants

pubmed: 33528847
doi: 10.1111/acps.13283
doi:

Types de publication

Journal Article Meta-Analysis Research Support, Non-U.S. Gov't Review Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

380-391

Informations de copyright

© 2021 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Références

Whiteford HA, Degenhardt L, Rehm J, et al. Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010. Lancet. 2013;382(9904):1575-1586. https://doi.org/10.1016/S0140-6736(13)61611-6
Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the national comorbidity survey replication. Arch Gen Psychiatry. 2005;62(6):593-602. https://doi.org/10.1001/archpsyc.62.6.593
Zhu T, De Luca V, Gallaugher LA, et al. Admixture analysis of age at onset in major depressive disorder. Gen Hosp Psychiatry. 2012;34(6):686-691. https://doi.org/10.1016/j.genhosppsych.2012.06.010
Pinna M, Visioli C, Rago CM, Manchia M, Tondo L, Baldessarini RJ. Attention deficit-hyperactivity disorder in adult bipolar disorder patients. J Affect Disord. 2019;243:391-396. https://doi.org/10.1016/j.jad.2018.09.038
Vannucchi G, Medda P, Pallucchini A, et al. The relationship between attention deficit hyperactivity disorder, bipolarity and mixed features in major depressive patients: Evidence from the BRIDGE-II-Mix Study. J Affect Disord. 2019;246:346-354. https://doi.org/10.1016/j.jad.2018.12.089
Polanczyk G, de Lima MS, Horta BL, Biederman J, Rohde LA. The worldwide prevalence of ADHD: a systematic review and metaregression analysis. AJP. 2007;164(6):942-948. https://doi.org/10.1176/ajp.2007.164.6.942
Fayyad J, Sampson NA, Hwang I, et al. The descriptive epidemiology of DSM-IV Adult ADHD in the World Health Organization World Mental Health Surveys. Atten Defic Hyperact Disord. 2017;9(1):47-65. https://doi.org/10.1007/s12402-016-0208-3
Propper L, Ortiz A, Slaney C, et al. Early-onset and very-early-onset bipolar disorder: distinct or similar clinical conditions? Bipolar Disord. 2015;17(8):814-820. https://doi.org/10.1111/bdi.12346
Jaideep T, Reddy YJ, Srinath S. Comorbidity of attention deficit hyperactivity disorder in juvenile bipolar disorder. Bipolar Disord. 2006;8(2):182-187. https://doi.org/10.1111/j.1399-5618.2006.00293.x
Yorbik O, Birmaher B, Axelson D, Williamson DE, Ryan ND. Clinical characteristics of depressive symptoms in children and adolescents with major depressive disorder. J Clin Psychiatry. 2004;65(12):1654-1659.
Gorlin EI, Dalrymple K, Chelminski I, Zimmerman M. Diagnostic profiles of adult psychiatric outpatients with and without attention deficit hyperactivity disorder. Compr Psychiatry. 2016;70:90-97. https://doi.org/10.1016/j.comppsych.2016.06.015
Schenkel LS, Pavuluri MN, Herbener ES, Harral EM, Sweeney JA. Facial emotion processing in acutely ill and euthymic patients with pediatric bipolar disorder. J Am Acad Child Adolesc Psychiatry. 2007;46(8):1070-1079. https://doi.org/10.1097/chi.0b013e3180600fd6
McCleary L, Sanford M. Parental expressed emotion in depressed adolescents: prediction of clinical course and relationship to comorbid disorders and social functioning. J Child Psychol Psychiatry. 2002;43(5):587-595. https://doi.org/10.1111/1469-7610.00048
Duran Ş, Fıstıkcı N, Keyvan A, Bilici M, Çalışkan M. ADHD in adult psychiatric outpatients: prevalence and comorbidity. Turk Psikiyatri Derg. 2014;25(2):84-93.
Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Medicine. 2009;6(7):e1000100. https://doi.org/10.1371/journal.pmed.1000100
Ghandour RM, Sherman LJ, Vladutiu CJ, et al. Prevalence and treatment of depression, anxiety, and conduct problems in US children. J Pediatrics. 2019;206:256-267.e3. https://doi.org/10.1016/j.jpeds.2018.09.021
Recommendations | Attention deficit hyperactivity disorder: diagnosis and management | Guidance | NICE. Accessed December 6, 2019. https://www.nice.org.uk/guidance/ng87/chapter/Recommendations
Raiker JS, Freeman AJ, Perez-Algorta G, Frazier TW, Findling RL, Youngstrom EA. Accuracy of Achenbach scales in the screening of attention-deficit/hyperactivity disorder in a community mental health clinic. J Am Acad Child Adolesc Psychiatry. 2017;56(5):401-409. https://doi.org/10.1016/j.jaac.2017.02.007
Klein DN, Santiago NJ. Dysthymia and chronic depression: Introduction, classification, risk factors, and course. J Clin Psychol. 2003;59(8):807-816. https://doi.org/10.1002/jclp.10174
Barendregt JJ, Doi SA, Lee YY, Norman RE, Vos T. Meta-analysis of prevalence. J Epidemiol Community Health. 2013;67(11):974-978. https://doi.org/10.1136/jech-2013-203104
Lee PH, Anttila V, Won H, et al. Genomic Relationships, Novel Loci, and Pleiotropic Mechanisms across Eight Psychiatric Disorders. Cell. 2019;179(7):1469-1482.e11. https://doi.org/10.1016/j.cell.2019.11.020.
Sandstrom A, Sahiti Q, Pavlova B, Uher R. Offspring of parents with schizophrenia, bipolar disorder, and depression: a review of familial high-risk and molecular genetics studies. Psychiatr Genet. 2019;29(5):160. https://doi.org/10.1097/YPG.0000000000000240
Sandstrom A, MacKenzie L, Pizzo A, et al. Observed psychopathology in offspring of parents with major depressive disorder, bipolar disorder and schizophrenia. Psychol Med. 2020;50(6):1050-1056. https://doi.org/10.1017/S0033291719001089
Dvir Y, Ford JD, Hill M, Frazier JA. Childhood maltreatment, emotional dysregulation, and psychiatric comorbidities. Harv Rev Psychiatry. 2014;22(3):149-161. https://doi.org/10.1097/HRP.0000000000000014
Drew N, Knapp M, Funk M. Mental health, poverty and development. J Public Mental Health. 2012;11(4):166-185. https://doi.org/10.1108/17465721211289356
Pavlova B, Perroud N, Cordera P, Uher R, Dayer A, Aubry J-M. Childhood maltreatment and comorbid anxiety in people with bipolar disorder. J Affect Disord. 2016;192:22-27. https://doi.org/10.1016/j.jad.2015.12.002
Newark PE, Elsässer M, Stieglitz R-D. Self-esteem, self-efficacy, and resources in adults with ADHD. J Atten Disord. 2016;20(3):279-290. https://doi.org/10.1177/1087054712459561
Henriksen IO, Ranøyen I, Indredavik MS, Stenseng F. The role of self-esteem in the development of psychiatric problems: a three-year prospective study in a clinical sample of adolescents. Child Adolesc Psychiatry Ment Health. 2017;11: https://doi.org/10.1186/s13034-017-0207-y
Zwicker A, MacKenzie LE, Drobinin V, et al. Neurodevelopmental and genetic determinants of exposure to adversity among youth at risk for mental illness. J Child Psychol Psychiatry. 2020;61(5):536-544. https://doi.org/10.1111/jcpp.13159
Biederman J, Petty CR, Byrne D, Wong P, Wozniak J, Faraone SV. Risk for switch from unipolar to bipolar disorder in youth with ADHD: A long term prospective controlled study. J Affect Disord. 2009;119(1-3):16-21. https://doi.org/10.1016/j.jad.2009.02.024
Marangoni C, De Chiara L, Faedda GL. Bipolar disorder and ADHD: comorbidity and diagnostic distinctions. Curr Psychiatry Rep. 2015;17(8):67. https://doi.org/10.1007/s11920-015-0604-y
Birmaher B. Bipolar disorder in children and adolescents. Child Adolesc Mental Health. 2013;18(3):140-148. https://doi.org/10.1111/camh.12021
Pavuluri MN, Birmaher B, Naylor MW. Pediatric bipolar disorder: a review of the past 10 years. J Am Acad Child Adolesc Psychiatry. 2005;44(9):846-871. https://doi.org/10.1097/01.chi.0000170554.23422.c1
Holtmann M, Bölte S, Poustka F. Rapid increase in rates of bipolar diagnosis in youth: “true” bipolarity or misdiagnosed severe disruptive behavior disorders? Arch Gen Psychiatry. 2008;65(4):477. https://doi.org/10.1001/archpsyc.65.4.477
Biederman J, Faraone S, Wozniak J, et al. Clinical correlates of bipolar disorder in a large, referred sample of children and adolescents. J Psychiatr Res. 2005;39(6):611-622. http://dx.doi.org/10.1016/j.jpsychires.2004.08.003
Faraone SV, Biederman J, Mick E. The age-dependent decline of attention deficit hyperactivity disorder: a meta-analysis of follow-up studies. Psychol Med. 2006;36(2):159-165. https://doi.org/10.1017/S003329170500471X
Post RM, Altshuler LL, Kupka R, et al. More childhood onset bipolar disorder in the United States than Canada or Europe: Implications for treatment and prevention. Neurosci Biobehav Rev. 2017;74:204-213. https://doi.org/10.1016/j.neubiorev.2017.01.022
Thomas R, Sanders S, Doust J, Beller E, Glasziou P. Prevalence of attention-deficit/hyperactivity disorder: a systematic review and meta-analysis. Pediatrics. 2015;135(4):e994-e1001. https://doi.org/10.1542/peds.2014-3482
Clacey J, Goldacre M, James A. Paediatric bipolar disorder: international comparisons of hospital discharge rates 2000-2010. BJPsych Open. 2015;1(2):166-171. https://doi.org/10.1192/bjpo.bp.115.001933
McIntosh D, Kutcher S, Binder C, Levitt A, Fallu A, Rosenbluth M. Adult ADHD and comorbid depression: A consensus-derived diagnostic algorithm for ADHD. Neuropsychiatr Dis Treat. 2009;5:137-150.
Goodman D. Adult ADHD and comorbid depressive disorders: diagnostic challenges and treatment options. CNS Spectr. 2009;14(S6):5-7. https://doi.org/10.1017/S1092852900024810
Brus M, Solanto M, Goldberg J. Adult ADHD vs. bipolar disorder in the DSM-5 Era: A challenging differentiation for clinicians. J Psychiatric Pract. 2014;20(6):428-437. https://doi.org/10.1097/01.pra.0000456591.20622.9e
Bond DJ, Hadjipavlou G, Lam RW, et al. The Canadian Network for Mood and Anxiety Treatments (CANMAT) task force recommendations for the management of patients with mood disorders and comorbid attention-deficit/hyperactivity disorder. Annals Clin Psychiatry 15.
Simon NM, Otto MW, Weiss RD, et al. Pharmacotherapy for bipolar disorder and comorbid conditions. J Clin Psychopharmacol. 2004;24(5):512-520. http://dx.doi.org/10.1097/01.jcp.0000138772.40515.70
Weiss M, Murray C, Wasdell M, Greenfield B, Giles L, Hechtman L. A randomized controlled trial of CBT therapy for adults with ADHD with and without medication. BMC Psychiatry. 2012;12(1):30. https://doi.org/10.1186/1471-244X-12-30
Driessen E, Hollon SD. Cognitive behavioral therapy for mood disorders: efficacy, moderators and mediators. Psychiatr Clin North Am. 2010;33(3):537-555. https://doi.org/10.1016/j.psc.2010.04.005
Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Medicine. 2009;6(7):e1000097. https://doi.org/10.1371/journal.pmed.1000097

Auteurs

Andrea Sandstrom (A)

Department of Psychiatry, Dalhousie University, Halifax, NS, Canada.
Nova Scotia Health Authority, Halifax, NS, Canada.

Nader Perroud (N)

Department of Psychiatry, Dalhousie University, Halifax, NS, Canada.
Department of Psychiatry, Faculty of Medicine, University of Geneva, Geneva, Switzerland.
Division of Psychiatric Specialties, Department of Psychiatry, Geneva University Hospitals, Geneva, Switzerland.

Martin Alda (M)

Department of Psychiatry, Dalhousie University, Halifax, NS, Canada.
Nova Scotia Health Authority, Halifax, NS, Canada.

Rudolf Uher (R)

Department of Psychiatry, Dalhousie University, Halifax, NS, Canada.
Nova Scotia Health Authority, Halifax, NS, Canada.

Barbara Pavlova (B)

Department of Psychiatry, Dalhousie University, Halifax, NS, Canada.
Nova Scotia Health Authority, Halifax, NS, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH